Shamburg News · 8-K filed Nov 13, 2026, 8:35 AM EST

MetaVia Reports Third Quarter 2026 Results and Provides Corporate Update

MTVA · MetaVia Inc.

  • Earnings
  • Leadership change
  • Reg FD disclosure
  • Materiality: high

MetaVia Inc. reported a net loss of $4.6 million, or $0.69 per basic and diluted share, for the third quarter ended September 30, 2026, compared with a net loss of $3.4 million, or $1.52 per share, a year earlier. The company reported cash and cash equivalents of $8.8 million as of September 30, 2026, and a corporate update including the appointment of Sarah Browne, M.D., as Chief Medical Officer. The company also posted an updated corporate presentation furnished as Exhibit 99.2.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 2.02, 7.01, 9.01, accession 0001104659-26-126540.

Written from the filing by Shamburg Markets. Figures are as reported by the company.